Mn Services Vermogensbeheer B.V. Purchases 4,200 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Mn Services Vermogensbeheer B.V. has increased its stake in Intuitive Surgical, Inc. by 3.2%, acquiring an additional 4,200 shares, bringing its total ownership to 133,900 shares valued at approximately $72.8 million.
• Multiple hedge funds have significantly increased their investments in Intuitive Surgical, with total institutional ownership now at 83.64%.
• Analysts remain bullish, with the stock receiving several "buy" ratings and price target increases, leading to an average target price of $595.95 and a consensus rating of "Moderate Buy".

Mn Services Vermogensbeheer B.V. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 133,900 shares of the medical equipment provider's stock after acquiring an additional 4,200 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Intuitive Surgical were worth $72,763,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Nuveen LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $1,715,899,000. GAMMA Investing LLC boosted its stake in Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Intuitive Surgical by 26.1% in the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after acquiring an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 1.3%

Shares of NASDAQ:ISRG traded up $5.83 during midday trading on Monday, reaching $444.55. 2,652,022 shares of the company were exchanged, compared to its average volume of 2,373,186. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a fifty day simple moving average of $475.20 and a two-hundred day simple moving average of $502.92. The firm has a market cap of $159.36 billion, a PE ratio of 62.00, a P/E/G ratio of 4.60 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the business posted $1.78 earnings per share. The firm's quarterly revenue was up 21.4% on a year-over-year basis. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. Insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. UBS Group lifted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. BTIG Research lifted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, Evercore ISI lifted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Thirteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.